Treatment of mucocutaneous candidiasis with transfer factor

R. D. Feigin, P. G. Shackelford, S. Eisen

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Evaluation of a patient with chronic mucocutaneous candidiasis revealed that the patient lacked delayed hypersensitivity to candida and other skin test antigens and the patient's lymphocytes could not be stimulated in vitro with candida antigen. Phytohemagglutinin stimulation of lymphocytes in vitro was normal. Candidacidal function and myeloperoxidase activity of the patient's leukocytes were normal. The patient's lymphocytes produced migration inhibitory factor in response to candida antigen and the monocyte receptor sites for IgG were intact. Repeated treatments with amphotericin B, alone or with 5 fluorocytosine, were followed by immediate relapse. Four doses of transfer factor were administered and when coupled with amphotericin B on 2 occasions prompted remissions of 6 and 4 mth, respectively.

Original languageEnglish
Pages (from-to)63-70
Number of pages8
Issue number1
StatePublished - 1974


Dive into the research topics of 'Treatment of mucocutaneous candidiasis with transfer factor'. Together they form a unique fingerprint.

Cite this